L1CAM
Neural cell adhesion molecule L1
Also known as: CAML1, CD171, HSAS, HSAS1, L1CAM_HUMAN, MASA, MIC5, NCAM-L1, S10, SPG1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P32004
- Gene
- L1CAM
- Ensembl
- ENSG00000198910
- Chromosome
- X
- Canonical length
- 1257 aa
- Protein class
- CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Nucleoplasm,Plasma membrane
OverviewNCBI Gene
The protein encoded by this gene is an axonal glycoprotein belonging to the immunoglobulin supergene family. The ectodomain, consisting of several immunoglobulin-like domains and fibronectin-like repeats (type III), is linked via a single transmembrane sequence to a conserved cytoplasmic domain. This cell adhesion molecule plays an important role in nervous system development, including neuronal migration and differentiation. Mutations in the gene cause X-linked neurological syndromes known as CRASH (corpus callosum hypoplasia, retardation, aphasia, spastic paraplegia and hydrocephalus). Alternative splicing of this gene results in multiple transcript variants, some of which include an alternate exon that is considered to be specific to neurons. [provided by RefSeq, May 2013]
Canonical amino-acid sequenceUniProt
1257 residues, UniProt reviewed canonical sequence.
>P32004|L1CAM
1 MVVALRYVWP LLLCSPCLLI QIPEEYEGHH VMEPPVITEQ SPRRLVVFPT DDISLKCEAS
61 GKPEVQFRWT RDGVHFKPKE ELGVTVYQSP HSGSFTITGN NSNFAQRFQG IYRCFASNKL
121 GTAMSHEIRL MAEGAPKWPK ETVKPVEVEE GESVVLPCNP PPSAEPLRIY WMNSKILHIK
181 QDERVTMGQN GNLYFANVLT SDNHSDYICH AHFPGTRTII QKEPIDLRVK ATNSMIDRKP
241 RLLFPTNSSS HLVALQGQPL VLECIAEGFP TPTIKWLRPS GPMPADRVTY QNHNKTLQLL
301 KVGEEDDGEY RCLAENSLGS ARHAYYVTVE AAPYWLHKPQ SHLYGPGETA RLDCQVQGRP
361 QPEVTWRING IPVEELAKDQ KYRIQRGALI LSNVQPSDTM VTQCEARNRH GLLLANAYIY
421 VVQLPAKILT ADNQTYMAVQ GSTAYLLCKA FGAPVPSVQW LDEDGTTVLQ DERFFPYANG
481 TLGIRDLQAN DTGRYFCLAA NDQNNVTIMA NLKVKDATQI TQGPRSTIEK KGSRVTFTCQ
541 ASFDPSLQPS ITWRGDGRDL QELGDSDKYF IEDGRLVIHS LDYSDQGNYS CVASTELDVV
601 ESRAQLLVVG SPGPVPRLVL SDLHLLTQSQ VRVSWSPAED HNAPIEKYDI EFEDKEMAPE
661 KWYSLGKVPG NQTSTTLKLS PYVHYTFRVT AINKYGPGEP SPVSETVVTP EAAPEKNPVD
721 VKGEGNETTN MVITWKPLRW MDWNAPQVQY RVQWRPQGTR GPWQEQIVSD PFLVVSNTST
781 FVPYEIKVQA VNSQGKGPEP QVTIGYSGED YPQAIPELEG IEILNSSAVL VKWRPVDLAQ
841 VKGHLRGYNV TYWREGSQRK HSKRHIHKDH VVVPANTTSV ILSGLRPYSS YHLEVQAFNG
901 RGSGPASEFT FSTPEGVPGH PEALHLECQS NTSLLLRWQP PLSHNGVLTG YVLSYHPLDE
961 GGKGQLSFNL RDPELRTHNL TDLSPHLRYR FQLQATTKEG PGEAIVREGG TMALSGISDF
1021 GNISATAGEN YSVVSWVPKE GQCNFRFHIL FKALGEEKGG ASLSPQYVSY NQSSYTQWDL
1081 QPDTDYEIHL FKERMFRHQM AVKTNGTGRV RLPPAGFATE GWFIGFVSAI ILLLLVLLIL
1141 CFIKRSKGGK YSVKDKEDTQ VDSEARPMKD ETFGEYRSLE SDNEEKAFGS SQPSLNGDIK
1201 PLGSDDSLAD YGGSVDVQFN EDGSFIGQYS GKKEKEAAGG NDSSGATSPI NPAVALELocalizationUniProt · AlphaFold · HPA
Whether an antibody against L1CAM can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.34
- Highest tissue expression
- 134 nTPM
Expression across tissuesHPA
Tissue
- cerebellum: 134 nTPM
- cerebral cortex: 52 nTPM
- colon: 48 nTPM
- hypothalamus: 44 nTPM
- basal ganglia: 29 nTPM
- adrenal gland: 26 nTPM
Single-cell type
- schwann cells: 187 nCPM
- adrenal medulla cells: 85 nCPM
- melanocytes: 48 nCPM
- other brain neurons: 44 nCPM
- renal collecting duct principal cells: 41 nCPM
- retinal ganglion cells: 35 nCPM
Immune cell
- naive B-cell: 0.5 nTPM
- memory B-cell: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
Brain region
- hypothalamus: 201 nTPM
- cerebral cortex: 198 nTPM
- basal ganglia: 150 nTPM
- cerebellum: 148 nTPM
- white matter: 134 nTPM
- pons: 123 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about L1CAM.
Disease | AllUniProt
Conditions L1CAM is implicated in, by any mechanism.
- Hydrocephalus, congenital, X-linked (HYCX) MIM:307000
- MASA syndrome (MASA) MIM:303350
- Agenesis of the corpus callosum, X-linked, partial (ACCPX) MIM:304100
Disease | GeneticClinVar
204 pathogenic / likely-pathogenic of 1,535 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Spastic paraplegia
- X-linked hydrocephalus syndrome
- MASA syndrome
- L1 syndrome
- X-linked complicated corpus callosum dysgenesis
ReferencesPubMed · IEDB
Publications for L1CAM from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
2 publications
- Circulating levels of autoantibodies against L1-cell adhesion molecule as a potential diagnostic biomarker in esophageal squamous cell carcinoma.
2017 · Clin Transl Oncol · RCR 0.3 · 9 citations - Identification of autoantibodies against L1CAM in patients with schizophrenia.
2026 · Brain Behav Immun Health
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.13
- gnomAD pLI
- 1
- gnomAD missense Z
- 2.84
- DepMap mean gene effect
- -0.05
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- axon development
- axon guidance
- cell adhesion
- cell migration
- cell-matrix adhesion
- chemotaxis
- homophilic cell adhesion via plasma membrane adhesion molecules
- nervous system development
- neuron projection development
- positive regulation of axon extension
- synapse organization
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Immunoglobulin subtype 2
- Immunoglobulin domain subtype
- Fibronectin type III
- Immunoglobulin-like domain
- Immunoglobulin I-set
- Immunoglobulin-like fold
- Neurofascin/L1/NrCAM, C-terminal domain
- Fibronectin type III superfamily
- Immunoglobulin-like domain superfamily
- Neural and epithelial cell adhesion domain-containing protein
- Fibronectin type III domain
- Immunoglobulin I-set domain
- Bravo-like intracellular region
- Immunoglobulin domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of L1CAM in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads L1CAM as an antibody target. Whether an autoantibody or antibody against L1CAM could matter depends on whether native L1CAM is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
L1CAM is annotated at the cell surface, where native L1CAM is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label L1CAM as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...